Leading Innovation in the Life Sciences
Discover the 150+ academic medical centers, commercial labs, incubators, accelerators, and programs and services leading life sciences in New York State.
Funding
Investing in innovation
Careers
Your future starts here
The Latest
NewYorkBIO & Diaceutics present: Drinks and Diagnostics
Join NewYorkBIO for a networking event with Diaceutics. The event will feature a night of learning and networking. Please note that approval is required for registration and priority will be given to NewYorkBIO members and invited guests. Attendance is limited to life science therapeutics company leaders. Service providers will not be approved for attendance of…
After the Winter: Life Science’s New Era of Capital & Conviction
The Savills NYC Life Sciences Team is hosting an evening with Nucleate NY and NewYorkBIO, bringing together a strong group of early and late-stage investors to talk openly about the forces reshaping the industry right now: rebounding deal volumes, FDA uncertainty, the surge in China licensing, shifting exit dynamics, and what it really takes to…
NewYorkBIO’s Statement on Resignation of FDA Commissioner Dr. Marty Makary
MSK for HBR: U.S. Medical Centers Need a New Model for Drug Discovery and Development
This Harvard Business Review article is primarily authored by leaders from Memorial Sloan Kettering Cancer Center (MSK), the New York–based cancer research and treatment institution. Four of the six authors are MSK leaders: Dr. Selwyn M. Vickers (President and CEO of MSK), Dr. Anaeze C. Offodile II (Executive Vice President and Chief Strategy Officer), Yashodhara…
Women’s Health Innovation in New York City
LifeSci NYC released a comprehensive analysis of New York City’s advantages across talent, capital, and public policy. Women’s health is emerging as one of the most compelling growth frontiers in life sciences and healthcare—and New York City is at the center of that momentum.
LIFE SCIENCES IN NEW YORK
Where science and opportunity come together
New York’s life science sector has attracted unprecedented investment, expanded research clusters across the state, and nurtured the growth of early-stage companies.
70,000
LIFE SCIENCES JOBS
25%
CLINICAL TRIALS IN THE U.S.
60%
PHARMACEUTICAL HEADQUARTERS